{
  "id": "57c3ca9094d5491d",
  "title": "Pharming Projects 27 % Revenue Growth In 2025 , Surpassing Prior Guidance , Driven By RUCONEST , Joenja",
  "description": "20260108T154500Z",
  "content": "",
  "source": "rttnews.com",
  "source_url": "https://www.rttnews.com/3608726/pharming-projects-27-revenue-growth-in-2025-surpassing-prior-guidance-driven-by-ruconest-joenja.aspx",
  "published_at": "20260108T154500Z",
  "fetched_at": "2026-01-09T00:23:18.491015+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.rttnews.com/3608726/pharming-projects-27-revenue-growth-in-2025-surpassing-prior-guidance-driven-by-ruconest-joenja.aspx",
    "url_mobile": "",
    "title": "Pharming Projects 27 % Revenue Growth In 2025 , Surpassing Prior Guidance , Driven By RUCONEST , Joenja",
    "seendate": "20260108T154500Z",
    "socialimage": "",
    "domain": "rttnews.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}